Treats schizophrenia. ANDA 80365, held by Dr Reddys. Chlorpromazine Hydrochloride.
As of Nov 16, 2026, ANDA 80365 (Chlorpromazine Hydrochloride), held by Dr Reddys, was first approved by FDA on Feb 13, 1974, with 25 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE For the treatment of schizophrenia; to control nausea and vomiting; for relief of restlessness and apprehension before surgery; for acute intermittent porphyria; as an adjunct in the treatment of tetanus; to control the manifestations of the manic type of manic-depressive illness; for relief of intractable hiccups; for the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the followi…
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 13, 1974 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorpromazine Hydrochloride25MG/ML · injectable;injection | Chlorpromazine Hydrochloride | Rx |
| Feb 5, 2020 | Supplement 167Labeling · Standard review | Approved | None posted |
| Feb 23, 2017 | Supplement 166Labeling · Standard review | Approved | None posted |
| Nov 3, 2015 | Supplement 165Labeling | Approved | None posted |
| Feb 19, 1999 | Supplement 163Manufacturing | Approved | None posted |
| Feb 2, 1999 | Supplement 162Manufacturing | Approved | None posted |
| Mar 27, 1998 | Supplement 160Manufacturing | Approved | None posted |
| Dec 4, 1996 | Supplement 161Manufacturing | Approved | None posted |
| Aug 16, 1995 | Supplement 159Manufacturing | Approved | None posted |
| May 27, 1992 | Supplement 157Manufacturing | Approved | None posted |
| May 11, 1992 | Supplement 158Labeling | Approved | None posted |
| Jul 2, 1991 | Supplement 152Manufacturing | Approved | None posted |
| Jul 2, 1991 | Supplement 151Manufacturing | Approved | None posted |
| Jul 2, 1991 | Supplement 150Manufacturing | Approved | None posted |
| Apr 10, 1991 | Supplement 156Labeling | Approved | None posted |
| Jan 11, 1990 | Supplement 155Labeling | Approved | None posted |
| Oct 16, 1989 | Supplement 153Manufacturing | Approved | None posted |
| Oct 16, 1989 | Supplement 149Manufacturing | Approved | None posted |
| Oct 16, 1989 | Supplement 148Manufacturing | Approved | None posted |
| Apr 20, 1989 | Supplement 138Bioequivalence | Approved | None posted |
| Apr 18, 1989 | Supplement 147Manufacturing | Approved | None posted |
| Apr 18, 1989 | Supplement 146Manufacturing | Approved | None posted |
| Apr 18, 1989 | Supplement 145Manufacturing | Approved | None posted |
| Apr 10, 1989 | Supplement 139Bioequivalence | Approved | None posted |
| Jun 30, 1988 | Supplement 41Labeling | Approved | None posted |
| Jun 16, 1986 | Supplement 137Manufacturing | Approved | None posted |
| Feb 13, 1974 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters